About BMEYE
BMEYE is a company based in Amsterdam (Netherlands) founded in 2005 was acquired by Edwards Lifesciences in October 2012.. BMEYE has raised $8.82 million across 3 funding rounds from investors including Edwards Lifesciences, Life Sciences Partners and 360 Capital Partners. BMEYE operates in a competitive market with competitors including Endotronix, Edwards Lifesciences, Flosonics Medical, Bardy Diagnostics and Bloomer Tech, among others.
- Headquarter Amsterdam, Netherlands
-
Sectors
HealthcareTechnology
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$8.82 M (USD)
in 3 rounds
-
Latest Funding Round
$8.82 M (USD), Series B
Oct 08, 2009
-
Investors
Edwards Lifesciences
& 5 more
-
Employee Count
Employee Count
-
Acquired by
Edwards Lifesciences
(Oct 10, 2012)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of BMEYE
BMEYE has successfully raised a total of $8.82M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $8.82 million completed in October 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $8.8M
- First Round First Round
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2009 | Amount | Series B - BMEYE | Valuation | 360 Capital Partners , Earlybird | |
| Jan, 2009 | Amount | Series A - BMEYE | Valuation |
investors |
|
| Dec, 2006 | Amount | Seed - BMEYE | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BMEYE
BMEYE has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Edwards Lifesciences, Life Sciences Partners and 360 Capital Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in digital tech startups
|
Founded Year | Domain | Location | |
|
Earlybird is recognized as a venture capital investor focused on early-stage tech companies.
|
Founded Year | Domain | Location | |
|
Private equity investments in life sciences businesses are managed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BMEYE
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BMEYE
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bmeye Comparisons
Competitors of BMEYE
BMEYE operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Endotronix, Edwards Lifesciences, Flosonics Medical, Bardy Diagnostics and Bloomer Tech, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring.
|
|
| domain | founded_year | HQ Location |
Medical devices for structural heart disease are developed and provided.
|
|
| domain | founded_year | HQ Location |
Developer of non-invasive hemodynamic monitoring devices
|
|
| domain | founded_year | HQ Location |
Develops and markets the Carnation Ambulatory Monitor
|
|
| domain | founded_year | HQ Location |
Smart innerwear with embedded sensors for cardiac monitoring is provided.
|
|
| domain | founded_year | HQ Location |
Non-invasive cardiac output and hemodynamic monitoring devices are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about BMEYE
When was BMEYE founded?
BMEYE was founded in 2005 and raised its 1st funding round 1 year after it was founded.
Where is BMEYE located?
BMEYE is headquartered in Amsterdam, Netherlands.
Who is the current CEO of BMEYE?
William Bednarski is the current CEO of BMEYE.
Is BMEYE a funded company?
BMEYE is a funded company, having raised a total of $8.82M across 3 funding rounds to date.
What does BMEYE do?
BMEYE is a engaged in the research and development of medical technologies for non-invasive cardiovascular monitoring. It offers finger arterial pressure and cardiac output technologies. The companys products include Finapres, a non-invasive continuous finger blood pressure monitor; Portapres, an ambulatory non-invasive continuous finger blood pressure monitor for measurements; Finometer, a stationary monitor with options for non-invasive brachial pressure and beat-to-beat hemodynamics; and BeatScope, a software package for the analysis of arterial pressure waveforms. Its products also comprise Modelflow, a model-based measurement method to compute the aortic flow waveform and cardiac output from an arterial blood pressure waveform; Space instrumentation, a version of finger blood pressure monitors; Cardiopres, an ambulatory device for research on the interaction of electrophysiology, hemodynamics, and respiration; and Oxyflow, a hemodynamics and oxygen delivery monitor for experimental applications. It also offers Nexfin, a non invasive blood pressure and cardiac output monitor, as well as ccNexfin for applications in various areas, such as cardiology, anesthesiology, sleep observation, physiology, neurology, and internal medicine; and emergency, acute, intensive, and intermediate care.
Who are the top competitors of BMEYE?
BMEYE's top competitors include Endotronix, Edwards Lifesciences and Flosonics Medical.
Who are BMEYE's investors?
BMEYE has 6 investors. Key investors include Edwards Lifesciences, Life Sciences Partners, 360 Capital Partners, Earlybird, and TECHFUND.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.